Scri Oncology Partners — Nashville, Tennessee

Scri Oncology Partners is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Scri Oncology Partners has participated in 6 clinical trials with 6 currently active.

Therapeutic areas: Solid Tumors, Hematologic Malignancies, Metastatic Hepatocellular Carcinoma.

Sponsors: Incyte Corporation, BeOne Medicines, Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Scri Oncology Partners?

Scri Oncology Partners has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Scri Oncology Partners conducted?

Scri Oncology Partners has 6 clinical trials on record, with 6 currently active. Their work covers Solid Tumors, Hematologic Malignancies, Metastatic Hepatocellular Carcinoma.

Is Scri Oncology Partners accredited by Crixeo Health?

Scri Oncology Partners has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Scri Oncology Partners?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.